(Q33285254)

25 July 2017

title

Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification (English)

1 reference

decision-tree classification

25 July 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

Jiefeng Cui

1

1 reference

25 July 2017

Xiaonan Kang

2

1 reference

25 July 2017

Zhi Dai

3

1 reference

25 July 2017

Cheng Huang

4

1 reference

25 July 2017

Haijun Zhou

5

1 reference

25 July 2017

Kun Guo

6

1 reference

25 July 2017

Yan Li

7

1 reference

25 July 2017

Yu Zhang

8

1 reference

25 July 2017

Ruixia Sun

9

1 reference

25 July 2017

Jie Chen

10

1 reference

25 July 2017

Yang Li

11

1 reference

25 July 2017

Zhaoyou Tang

12

1 reference

25 July 2017

Toshimasa Uemura

13

1 reference

25 July 2017

Yinkun Liu

14

1 reference

25 July 2017

publication date

22 May 2007

1 reference

Journal of Cancer Research and Clinical Oncology

25 July 2017

published in

1 reference

25 July 2017

volume

133

1 reference

25 July 2017

issue

11

1 reference

25 July 2017

page(s)

825-834

1 reference

The discovery of the hepatitis viruses

25 July 2017

cites work

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0224-Y

21 January 2018

12 December 2020

Advances in Molecular Diagnosis of HBV Infection and Drug Resistance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0224-Y

New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0224-Y

Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes

21 January 2018

1 reference

12 December 2020

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

1 reference

12 December 2020

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

1 reference

12 December 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

12 December 2020

Hepatitis B virus infection--natural history and clinical consequences

1 reference

12 December 2020

1 reference

12 December 2020

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

1 reference

12 December 2020

Characterization of the low molecular weight human serum proteome

1 reference

12 December 2020

1 reference

12 December 2020

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

12 December 2020

Tight association of hepatocellular carcinoma with HBV infection in North China.

1 reference

12 December 2020

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

12 December 2020

The role of laparoscopy in the diagnosis of cirrhosis

1 reference

12 December 2020

Hepatic fibrosis: are any of the serum markers useful?

1 reference

12 December 2020

Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.

1 reference

12 December 2020

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification

1 reference

12 December 2020

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

1 reference

12 December 2020

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

12 December 2020

Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.

1 reference

12 December 2020

Changing scene in hepatitis B serology interpretation

1 reference

12 December 2020

Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study

1 reference

12 December 2020

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

12 December 2020

Hepatocellular carcinoma: from bedside to proteomics

1 reference

12 December 2020

Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics

1 reference

12 December 2020

The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma

1 reference

12 December 2020

Epidemiology of primary liver cancer

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.

1 reference

12 December 2020

10.1007/S00432-007-0224-Y

Identifiers

DOI

1 reference

25 July 2017

1 reference